Problems with Johnson and Johnson vaccine

(Washington, DC) — The FDA is limiting its emergency use authorization of the Johnson & Johnson COVID-19 vaccine. On Thursday, the FDA announced it is only approving the vaccine for adults who cannot get the other vaccines or who specifically request the J&J one. The move comes after some have experienced a rare blood clotting condition after receiving the vaccine. The director of the FDA’s Center for Biologics Evaluation and Research said Johnson & Johnson’s vaccine still plays a role in the pandemic.